Retour sur lavenir.net
   VASTNED 29.500 € (+0,34 %)     WDP 22.140 € (-2,64 %)     D'IETEREN GROUP 174.800 € (+0,92 %)     GBL 78.450 € (+0,58 %)     KINEPOLIS GROUP 38.100 € (0,00 %)     KBC ANCORA 87.500 € (+1,86 %)     GIMV 44.750 € (+0,45 %)     ARGENX SE 804.400 € (+0,93 %)     LOTUS BAKERIES 10 720.000 € (+0,37 %)     MELEXIS 70.650 € (-2,35 %)     UCB 246.000 € (+1,23 %)     ONTEX GROUP 2.190 € (+0,23 %)     DECEUNINCK 2.135 € (-2,95 %)     SHURGARD 25.550 € (+0,99 %)     AGFA-GEVAERT 0.371 € (+0,27 %)     CIE BOIS SAUVAGE 301.000 € (+0,33 %)     IMMOBEL 21.600 € (-0,46 %)     AGEAS 71.650 € (-0,21 %)     COLRUYT 38.000 € (-0,21 %)     AEDIFICA 70.050 € (-0,36 %)     ECONOCOM GROUP 1.410 € (-3,42 %)     ELIA GROUP 138.500 € (-0,22 %)     EXMAR 11.500 € (0,00 %)     ASCENCIO 52.300 € (0,00 %)     CMB.TECH 13.860 € (+0,87 %)     TUBIZE-FIN 209.800 € (+1,25 %)     EVS 27.050 € (+0,56 %)     SIPEF 93.100 € (+0,54 %)     BANQUP GROUP 2.100 € (0,00 %)     BEKAERT 42.050 € (+1,08 %)     PROXIMUS 6.115 € (+0,33 %)     KBC 122.400 € (+1,32 %)     NYXOAH 1.240 € (-4,62 %)     ENERGYVISION 14.900 € (+0,40 %)     JENSEN-GROUP 84.400 € (+0,48 %)     VAN DE VELDE 29.800 € (-0,67 %)     TINC 11.300 € (+0,36 %)     BREDERODE 102.400 € (+0,20 %)     FAGRON 23.250 € (+0,22 %)     VGP 84.400 € (+1,44 %)     DEME GROUP 168.000 € (+0,12 %)     UMICORE 20.280 € (+3,42 %)     SYENSQO 71.050 € (+1,57 %)     CFE 12.100 € (+1,68 %)     SOFINA 238.000 € (+1,45 %)     RETAIL ESTATES 65.900 € (+1,23 %)     BARCO 7.950 € (-0,56 %)     AZELIS GROUP 10.620 € (+0,28 %)     IBA 16.420 € (+2,11 %)     ONWARD MEDICAL 2.405 € (0,00 %)     RECTICEL 11.900 € (-0,17 %)     TESSENDERLO 20.800 € (+0,73 %)     ACKERMANS V.HAAREN 265.800 € (-0,08 %)     FLUXYS BELGIUM D 20.000 € (0,00 %)     CARE PROPERTY INV. 12.680 € (+0,48 %)     TITAN S.A. 50.450 € (+2,50 %)     CAMPINE 207.000 € (-1,43 %)     AB INBEV 71.640 € (+1,16 %)     HOME INVEST BE. 19.880 € (+0,81 %)     SOLVAY 26.420 € (-0,30 %)  
   ADVICENNE 1.648 € (+4,30 %)     KPN KON 4.101 € (-0,92 %)     ASM INTERNATIONAL 859.400 € (-1,63 %)     BNP PARIBAS ACT.A 105.920 € (+2,08 %)     SCHNEIDER ELECTRIC 268.050 € (+1,00 %)     VALEO 13.730 € (-2,31 %)     SHELL PLC 38.775 € (-1,07 %)     ING GROEP N.V. 28.950 € (+1,49 %)     ASML HOLDING 1 563.000 € (-1,03 %)     ABIVAX 112.800 € (-1,48 %)     COVIVIO 53.100 € (+0,38 %)     LEGRAND 134.300 € (-0,48 %)     2CRSI 27.580 € (+4,08 %)     DASSAULT AVIATION 299.200 € (-1,77 %)     ALTHEORA 0.400 € (+12,99 %)     TKH GROUP 42.980 € (-0,74 %)     HEINEKEN 76.420 € (+0,92 %)     ARCADIS 41.400 € (+5,08 %)     CROSSJECT 1.504 € (-2,21 %)     RISING STONE 50.000 € (+0,50 %)     EUROPLASMA 0.001 € (0,00 %)     S.E.B. 52.700 € (-4,70 %)     AKZO NOBEL 57.860 € (+2,81 %)     AYVENS 11.620 € (+0,17 %)     BAM GROEP KON 11.000 € (-2,05 %)     SAINT GOBAIN 74.160 € (+1,81 %)     BOUYGUES 47.540 € (-0,61 %)     FDJ UNITED 22.410 € (-0,22 %)     UBISOFT ENTERTAIN 4.825 € (+2,12 %)     LVMH 461.700 € (+1,80 %)     UNIFY GROUP 1.800 € (-2,91 %)     BROADPEAK 2.380 € (-9,51 %)     AALBERTS NV 41.660 € (+0,43 %)     DSM FIRMENICH AG 81.400 € (+0,94 %)     CA TOULOUSE 31 CCI 119.840 € (-1,72 %)     L'OREAL 374.700 € (+1,59 %)     STMICROELECTRONICS 46.765 € (-2,46 %)     BENETEAU 6.110 € (+1,50 %)     SARTORIUS STED BIO 167.300 € (+2,01 %)     KERING 242.300 € (+1,47 %)     PROSUS 36.755 € (+0,82 %)     CAPITAL B 0.477 € (+1,25 %)     EURAZEO 47.680 € (+5,91 %)     WORLDLINE 9.688 € (+2,67 %)     BE SEMICONDUCTOR 227.000 € (-1,26 %)     ATOS GROUP 30.080 € (+4,74 %)     TECHNIP ENERGIES 34.360 € (+1,06 %)     SIGNIFY NV 14.570 € (-8,82 %)     HEINEKEN HOLDING 70.500 € (+0,86 %)     REXEL 37.630 € (+0,24 %)     ACCOR 46.310 € (+2,07 %)     ADYEN 801.000 € (+0,70 %)     ASR NEDERLAND 69.960 € (+0,32 %)     CEGEDIM 10.100 € (-1,94 %)     SES 7.010 € (-3,11 %)     VERALLIA 18.660 € (-0,21 %)     EDENRED 26.410 € (+0,99 %)     LAKEFRONT BIOTHER. 24.500 € (-1,13 %)     THALES 236.400 € (-0,80 %)     HAVAS 18.550 € (+1,37 %)  
News Réglementées
26/06/2026 11:14

EQS-Adhoc: Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026

EQS-Ad-hoc: Evonik Industries AG / Key word(s): Forecast / Full year/Results / Half year
Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026

26-Jun-2026 / 11:14 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


Evonik Industries AG is already today publishing the following financial and forecast data for the second quarter of 2026 and raising its outlook for the financial year 2026.

Based on current financial and forecast data, Evonik expects an adjusted EBITDA* between €600 million and €650 million in the second quarter of 2026 (Q2 2025: €509 million). Current market expectations are at around €567 million (Vara Research analyst consensus as of May 27, 2026).

This positive earnings development is driven by both higher sales volumes and higher prices, alongside ongoing cost reductions. In the Advanced Technologies segment specifically, Evonik is benefiting from supply chain disruptions affecting Asian competitors who are currently facing raw material supply limitations.

This favorable situation is expected to weaken later in the year as global marine shipping stabilizes following the reopening of the Strait of Hormuz. As a result, uncertainties persist for the second half of the year. In the Animal Nutrition segment, however, Evonik currently expects that the positive momentum will continue into the third quarter.

According to current financial and forecast data, adjusted EBITDA* for the first half of 2026 is expected to be around €1.1 billion.

Based on these developments, Evonik is raising its outlook for the financial year 2026. The company now expects adjusted EBITDA* for the financial year 2026 to range between €2.0 billion and €2.2 billion (previously: €1.7 billion to €2.0 billion). In 2025, Evonik earned an adjusted EBITDA* of approximately €1.9 billion.

Regarding free cash flow*, Evonik continues to target a cash conversion rate of around 40 percent (2025: 37 percent). Free cash flow* in the second quarter is expected to be significantly better than in the prior year (Q2 2025: minus €211 million).

Evonik Industries AG will publish final figures for the second quarter of 2026 on August 4, 2026, as planned.

 

*Notes on key performance indicators (KPIs) can be found in the Financial and Sustainability Report 2025 of Evonik Industries AG starting on page 290.

 

The Financial and Sustainability Report 2025 is available at:

https://www.evonik.finance/Financial-and-Sustainability-Report

 

Contact/person making the notification:
Christoph Finke
Head of Investor Relations
+49 174 9931 647
christoph.finke@evonik.com



End of Inside Information

26-Jun-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:Evonik Industries AG
Rellinghauser Str. 1-11
45128 Essen
Germany
Phone:+49 (0) 201 177-01
Fax:+49 (0) 201 177-3475
E-mail:investor-relations@evonik.com
Internet:www.evonik.com
ISIN:DE000EVNK013
WKN:EVNK01
Indices:MDAX
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX; Luxembourg Stock Exchange
EQS News ID:2354872

 
End of AnnouncementEQS News Service

2354872  26-Jun-2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière